Humetrix demonstrates iBlueButton at UK expo

Editorial Staff | | Health Exec | Precision Medicine

Crossing into new markets, Calif.-based Humetrix showed off its mobile health information exchange app iBlueButton at the UK National Health Service Innovation Expo 2013 last week. The event, which took place on March 13 and 14 in London, was geared to European health IT professionals.

Humetrix joined EHR vendors Cerner and TPP to demonstrate data exchange on the mobile platform, according to its March 14 company press release. Humetrix showed how the iBlueButton consumer app can download a patient’s hospital discharge summary from a Cerner inpatient EMR and then share the record with the patient’s physician using mobile-to-mobile push technology.  Also, it showed how to download to a patient’s mobile device their health record as extracted from clinical software.

The iBlueButton technology, tailored to work with UK systems, is expected to be available to UK consumers this fall. The NHS faces a regulatory deadline of 2015 to make EHRs available and accessible to patients.

 

Editorial Staff

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Reimbursement update: What hospitals need to know about new Medicare payments for cardiac CT

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Cardiovascular Business
Stryker acquires Inari Medical for $4.9B

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.